BioBridges has been engaged by an emerging biotechnology company to oversee a series of US- and EU-based oncology studies as they move out of Ph1b and into dose expansion.
BioBridges has been engaged by an emerging clinical-stage biotechnology company to develop and enforce quality assurance processes and oversee general quality systems, document reviews, and audits.
BioBridges has been engaged by a California-based, oncology-focused biopharmaceutical company to ensure the accuracy and consistency of all clinical databases while maintaining the companies policies and procedures for gathering, analyzing and reporting clinical data.
SAN FRANCISCO, CA – BioBridges, a Career Portfolio® Management company providing integrated services to the life sciences community, is proud to announce and welcome Joshua Nelson as a Director of Client Services. Nelson will collaborate with emerging and established pharmaceutical, biotech, and medical device companies to engage highly skilled professionals who…
BioBridges has been engaged by an emerging, Philadelphia-based pharmaceutical company to develop risk management plans for an active IND in compliance with ICH E6(R2) guidelines.
BioBridges has been engaged by an established, oncology-focused pharmaceutical company to provide clinical data management support including; clean up and close out of several legacy studies, contributing to hands-on data management work, as well as providing guidance and mentorship to the existing internal team.
BioBridges has been engaged by an established, oncology-focused biopharmaceutical company to ensure the quality of ad-hoc documents including responses to regulatory agencies and protocol amendments.
A BioBridges team of professionals has been engaged to develop and submit an IND and supporting investigator’s brochure, clinical protocol, and model ICF for an established, Texas-based biopharmaceutical company.
BioBridges has been engaged to support an established, California based pharmaceutical company by providing clinical operations leadership, management, and strategy to ensure successful Phase I trial enrollment and future progression.
BioBridges has been engaged to provide pharmacovigilance expertise to an established pharmaceutical company by reviewing current pharmacovigilance procedures, identifying any gaps, and supporting the implementation of subsequent recommendations to ensure the success of future NDA filings and audits.